News

Hims & Hers (HIMS): A Bear Case Theory
We came across a bearish thesis on Hims & Hers on FJ Research’s Substack. As of 3ʳᵈ July, Hims & Hers’s share was trading at ...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses On Their Investment In Hims & Hers Health, Inc. Of Class Action Lawsuit And Upcoming Deadlines - HIMS
On this news, Hims & Hers' stock price fell $22.24 per share, or 34.63%, to close at $41.98 per share on June 23, 2025.
Managed Healthcare Executive51m
FDA Expands Kerendia’s Use to Treat Common Form of Heart Failure
Kerendia was originally approved in July 2021 to reduce cardiovascular and kidney complications in patients with chronic ...